185
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

External validation and comparison of simple ultrasound activity score and international bowel ultrasound segmental activity score for Crohn’s disease

, , , , & ORCID Icon
Pages 883-889 | Received 10 Oct 2022, Accepted 11 Feb 2023, Published online: 23 Feb 2023

References

  • Oliveira SB, Monteiro IM. Diagnosis and management of inflammatory bowel disease in children. BMJ. 2017;357:j2083.
  • Migaleddu V, Scanu AM, Quaia E, et al. Contrast-enhanced ultrasonographic evaluation of inflammatory activity in crohn’s disease. Gastroenterology. 2009;137(1):43–52.
  • Steenholdt C. Personalized therapy with TNF-inhibitors in crohn’s disease: optimizing treatment outcomes by monitoring drug levels and anti-drug antibodies. Dan Med J. 2016;63(8):B5270.
  • Tinmouth J, Kennedy EB, Baron D, et al. Colonoscopy quality assurance in Ontario: systematic review and clinical practice guideline. Can J Gastroenterol Hepatol. 2014;28(5):251–274.
  • Dik VK, Moons LM, Siersema PD. Endoscopic innovations to increase the adenoma detection rate during colonoscopy. World J Gastroenterol. 2014;20(9):2200–2211.
  • Kucharzik T, Wittig BM, Helwig U, TRUST study group, et al. Use of intestinal ultrasound to monitor Crohn’s disease activity. Clin Gastroenterol Hepatol. 2017;15(4):535–542.e2.
  • Bryant RV, Friedman AB, Wright EK, et al. Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application. Gut. 2018;67(5):973–985.
  • Kucharzik T, Maaser C. Intestinal ultrasound and management of small bowel crohn’s disease. Therap Adv Gastroenterol. 2018;11:1756284818771367.
  • Maaser C, Sturm A, Vavricka SR, , et al. ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications. J Crohns Colitis. 2019;13(2):144–164.
  • Sævik F, Eriksen R, Eide GE, et al. Development and validation of a simple ultrasound activity score for Crohn’s disease. J Crohns Colitis. 2021;15(1):115–124.
  • Novak KL, Nylund K, Maaser C, et al. Expert consensus on optimal acquisition and development of the international bowel ultrasound segmental activity score [IBUS-SAS]: a reliability and inter-rater variability study on intestinal ultrasonography in Crohn’s disease. J Crohns Colitis. 2021;15(4):609–616.
  • Maconi G, Nylund K, Ripolles T, et al. EFSUMB recommendations and clinical guidelines for intestinal ultrasound (GIUS) in inflammatory bowel diseases. EFSUMB-Empfehlungen und klinische leitlinien für den gastrointestinalen ultraschall (GIUS) chronisch entzündlichen darmerkrankungen (CED). Ultraschall Med. 2018;39(3):304–317.
  • Spalinger J, Patriquin H, Miron MC, et al. Doppler US in patients with crohn disease: vessel density in the diseased bowel reflects disease activity. Radiology. 2000;217(3):787–791.
  • Daperno M, D'Haens G, Van Assche G, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–512.
  • Novak KL, Kaplan GG, Panaccione R, et al. A simple ultrasound score for the accurate detection of inflammatory activity in Crohn’s disease. Inflamm Bowel Dis. 2017;23(11):2001–2010.
  • Liu C, Ding SS, Zhang K, et al. Correlation between ultrasound consolidated score and simple endoscopic score for determining the activity of Crohn’s disease. Br J Radiol. 2020;93(1109):20190614.
  • Jing J, Wu Y, Zhang H, et al. The establishment of a regression model from four modes of ultrasound to predict the activity of Crohn’s disease. Sci Rep. 2021;11(1):77.
  • Yamanashi K, Katsurada T, Nishida M, et al. Crohn’s disease activity evaluation by transabdominal ultrasonography: correlation with double-balloon endoscopy. J Ultrasound Med. 2021;40(12):2595–2605.
  • Futagami Y, Haruma K, Hata J, et al. Development and validation of an ultrasonographic activity index of crohn’s disease. Eur J Gastroenterol Hepatol. 1999;11(9):1007–1012.
  • Drews BH, Barth TF, Hänle MM, et al. Comparison of sonographically measured bowel wall vascularity, histology, and disease activity in Crohn’s disease. Eur Radiol. 2009;19(6):1379–1386.
  • Sasaki T, Kunisaki R, Kinoshita H, et al. Use of color Doppler ultrasonography for evaluating vascularity of small intestinal lesions in Crohn’s disease: correlation with endoscopic and surgical macroscopic findings. Scand J Gastroenterol. 2014;49(3):295–301.
  • Pascu M, Roznowski AB, Müller HP, et al. Clinical relevance of transabdominal ultrasonography and magnetic resonance imaging in patients with inflammatory bowel disease of the terminal ileum and large bowel. Inflamm Bowel Dis. 2004;10(4):373–382.
  • Bots S, Nylund K, Löwenberg M, et al. Ultrasound for assessing disease activity in IBD patients: a systematic review of activity scores. J Crohns Colitis. 2018;12(8):920–929.
  • Goodsall TM, Nguyen TM, Parker CE, et al. Systematic review: gastrointestinal ultrasound scoring indices for inflammatory bowel disease. J Crohns Colitis. 2021;15(1):125–142.
  • Dragoni G, Innocenti T, Lynch EN, et al. P141 IBUS-SAS for Crohn’s disease ultrasound activity: initial validation and research of the optimal cut-off score. J Crohns Colitis. 2021;(Supplement_1):Supplement_1.
  • Maconi G, Greco S, Duca P, et al. Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn’s disease. Inflamm Bowel Dis. 2008;14(11):1555–1561.
  • Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging. 2000;25(3):219–228.
  • Castiglione F, Imperatore N, Testa A, et al. One-year clinical outcomes with biologics in crohn’s disease: transmural healing compared with mucosal or no healing. Aliment Pharmacol Ther. 2019;49(8):1026–1039.
  • Goodsall TM, Jairath V, Feagan BG, et al. Standardisation of intestinal ultrasound scoring in clinical trials for luminal Crohn’s disease. Aliment Pharmacol Ther. 2021;53(8):873–886.
  • Freitas M, de Castro FD, Macedo Silva V, et al. Ultrasonographic scores for ileal crohn’s disease assessment: better, worse or the same as contrast-enhanced ultrasound? BMC Gastroenterol. 2022;22(1):252.
  • Fernandes SR, Rodrigues RV, Bernardo S, et al. Transmural healing is associated with improved long-term outcomes of patients with Crohn’s disease. Inflamm Bowel Dis. 2017;23(8):1403–1409.
  • Zorzi F, Ghosh S, Chiaramonte C, et al. Response assessed by ultrasonography as target of biological treatment for Crohn’s disease. Clin Gastroenterol Hepatol. 2020;18(9):2030–2037.
  • Allocca M, Craviotto V, Dell’Avalle C, et al. Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn’s disease. Aliment Pharmacol Ther. 2022;55(4):446–454.
  • Mosli MH, Zou G, Garg SK, et al. C-Reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and Meta-Analysis. Am J Gastroenterol. 2015;110(6):802–819; quiz 820.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.